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The monitoring of salivary cortisol as a key biomarker of an individual’s stress response
has been increasingly focused on. This paper describes the development of a novel corti-
sol immuno-assay method based on an indirect competitive method using a commercially
available surface plasmon resonance instrument. The surface of an Au chip was modified
with PEG6-COOH aromatic dialkanethiol self-assembled monolayers and hydrocortisone
3-(O-carboxymethyl) oxime (hydrocortisone 3-CMO) as a cortisol analog. A detection limit
of 38 ppt range with a measurement range of 10 ppt–100 ppb was accomplished without
the incubation of a mixing solution consisting of standard cortisol and an anti-cortisol anti-
body, and the time for quantification of cortisol concentration was 8 min from the sample
injection. We experimentally compared our immuno-assay with a commercialized salivary
cortisol enzyme-linked immunosorbent assay (ELISA) kit using human saliva samples. It
was found that the results obtained by the cortisol immuno-assay had a good correlation
with those obtained by ELISA assay (R=0.96). Our findings indicate the potential utility of
the cortisol immuno-assay for measurements of human salivary cortisol levels.
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INTRODUCTION
In the hypothalamus–pituitary–adrenal (HPA) axis, plasma, uri-
nary, and salivary cortisol, key biomarkers of an individual’s psy-
chological stress response, are being increasingly focused on in
psychobiological stress research (Kirschbaum and Hellhammer,
2007; Olff et al., 2007). Many research groups have reported the
relationship between the cortisol concentration and stress-related
disorders, including irritable bowel syndrome (IBS) (Patacchioli
et al., 2001), chronic fatigue syndrome (CFS) (Jerjes et al., 2006),
and posttraumatic stress disorder (PTSD) (Inslicht et al., 2006;
Johnson et al., 2008).
Salivary cortisol, in particular, is a major neuroendocrine corre-
lator of the neuroendocrine stress response and has been increas-
ingly studied as a stress biomarker (Hellhammer et al., 2009). Sali-
vary cortisol levels ranged between 0.1 and 10 ppb (ng/ml) (Aardal
and Holm, 1995). Our research group has focused on salivary cor-
tisol and its analytical method (Tahara et al., 2010), because saliva
can be collected sufficient volumes for biochemical analyses, with
some exceptions such as dry mouth patients, regardless of the time
and place by a non-invasive, and stress-free process without med-
ical personnel. The whole salivary secretion rate has been reported
approximately 1 ml/min (resting saliva) (Molander and Birkhed,
1981). The salivary cortisol level differs greatly among individuals
and with circadian variation (Adam et al., 2006). Other research
groups have reported that salivary cortisol levels are significantly
lower in IBS patients (Patacchioli et al., 2001) and that there is a
significant difference between depressed and healthy people with
regard to salivary cortisol levels when waking and 30 min after
waking (Alderling et al., 2008). However, immuno-assay-based
clinical auto analytical instruments are expensive and their use
is time-consuming. Conventional enzyme-linked immunosorbent
assay (ELISA) in labs usually takes approximately 4 h to complete
the analysis and multiple steps are required. Thus, the development
of rapid, portable, and easy-to-use analytical devices designed
to measure and rapidly report cortisol levels would have a great
impact on future research and the treatment of people with stress-
related disorders. Recently, various types of cortisol biosensors for
point-of-care testing (POCT), such as a polyaniline based electro-
chemical immunosensor (Arya et al., 2011; Kaushik et al., 2013;
Vasudev et al., 2013), an immunosensor with a fluid control mech-
anism (Yamaguchi et al., 2013), a single-walled carbon nanotubes
(SWNT) chemiresistor transducer-based cortisol immunosensor
(Tlili et al., 2011) have been proposed.
Our research group has developed a compact sensing system
using surface plasmon resonance (SPR) immunosensors for the
on-site detection of trinitrotoluene (MW: 227.1) (Mizuta et al.,
2008; Onodera et al., 2009; Onodera, 2013). SPR immunosen-
sors are realized by combining SPR sensors, which can be used to
detect changes in the refractive index of the sensor surface with
high-sensitivity, with an antigen–antibody interaction, resulting in
high selectivity. However, cortisol, a steroid hormone, is a mono-
valent antigen with a low molecular weight (362.47). Therefore,
the sandwich immuno-assay method cannot be applied. Other
research groups have reported an SPR immunosensor using a
direct competitive assay with primary and secondary antibod-
ies used for the amplification of signals [response time: 15 min
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from sample injection, assay dynamic range: 91–900 ppt, detec-
tion limit (the blank less two SDs of the blank) using standard
solution: 13 ppt] (Mitchell et al., 2009), using a direct assay with
polycarboxylate-hydrogel-based coating for the antibody immo-
bilization (response time: flowed over the sensors surface for
15 min, linear detection range: 5–154 ppb, detection limit using
standard solution: 10 ppb) (Frasconi et al., 2009), as well as an
SPR immunosensor using a cortisol-conjugated BSA-modified Au
chip as a cortisol analog (response time: 15 min from sample injec-
tion, detection range: 1.5–10 ppb, detection limit using standard
solution: 360 ppt) (Stevens et al., 2008).
In this study, we report a salivary cortisol immuno-assay
method using a commercially available SPR instrument and a
newly designed indirect competitive method for the quantitative
evaluation of human psychosomatic stress. To this end, we mod-
ified a sensor surface with PEG6-COOH aromatic dialkanethiol
self-assembled monolayers (SAMs) and hydrocortisone 3-CMO
as a cortisol analog for highly sensitive, accurate, and rapid detec-
tion. Moreover, we compared the characteristics of the cortisol
immuno-assay method a conventional ELISA assay using human
saliva.
MATERIALS AND METHODS
REAGENTS AND CHEMICALS
Mouse anti-cortisol monoclonal antibody (association constant
KA= 1.7× 109 M−1, cortisol antibody) was purchased from
Abcam PLC (UK). As the cortisol analog, hydrocortisone 3-(O-
carboxymethyl) oxime (hydrocortisone 3-CMO) was purchased
from Sigma Aldrich (USA). PEG6-COOH aromatic dialkanethiol
(PEG6-COOH) was purchased from SensoPath Technologies, Inc.
(USA), and was used as a reagent to form SAMs on the chip
surface. The Au sensor chip included in the SIA Kit, the N -ethyl-
N -(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)
included in an amine coupling kit, the N -hydroxysuccinimide
(NHS) for sensor surface fabrication, a borate buffer (pH 8.5,
10 mM disodium tetraborate, 1 M NaCl), and 50 mM NaOH were
purchased from GE Healthcare Bio-Science AB (Sweden). Ethyl-
enediamine was purchased from Wako Pure Chemical Industries,
Ltd. (Japan). An ELISA kit was used as a conventional salivary
cortisol detection method, and Salimetrics oral swabs, used as a
salivary collection material were purchased from Salimetrics LLC
(USA). Water purified using a Milli-Q integral water purifica-
tion system was used as the solvent. All aqueous solutions were
prepared with Milli-Q water obtained from a Milli-Q system
(Millipore Corporation, USA).
MODIFICATION OF SENSOR CHIP SURFACE
As a preliminary cleaning step, an Au sensor chip covered with
a 50-nm-thick layer of unmodified gold was first ultrasonically
cleaned in acetone for 10 min, ethanol for 2 min, and 2-propanol
for 2 min. Subsequently, the sensor surface was cleaned in standard
clean solution (a mixture of ammonia solution, hydrogen perox-
ide solution, and pure water with a ratio of 1:1:5) heated to 90°C
for 20 min. Modification of the sensor chip surface was performed
as follows (Figure 1): the sensing surface of the Au sensor chip was
immersed in 1 mM PEG6-COOH (Lahiri et al., 1999) in ethanol
for 24 h to form SAMs on the sensor surface. After cleaning with
ethanol by ultrasonication, a mixture solution consisting of 0.2 M
EDC in water and 50 mM NHS in water was added dropwise onto
the sensor surface and incubated for 30 min to activate the termi-
nal carboxyl group. Next, ethylenediamine in the pH 8.5 borate
buffer was added dropwise onto the sensor surface and incubated
for 30 min to induce amine coupling by covering the terminal
carboxyl group of the SAM into an amino group. Simultaneously,
10 mM hydrocortisone 3-CMO in DMF with a carboxyl group as a
cortisol analog, 0.4 M EDC in water, and 0.1 M NHS in DMF were
mixed with a volume ratio of 1:1:1 and incubated for 60 min to
activate the carboxyl group of the cortisol analog. The mixed solu-
tion was added dropwise onto the sensor surface and incubated for
60 min. Finally, the cortisol analog was bound to ethylenediamine
immobilized on the film surface as a result of amine coupling.
CORTISOL DETECTION USING SPR IMMUNOSENSOR BY INDIRECT
COMPETITIVE ASSAY
Cortisol detection was performed by SPR using a Biacore J sys-
tem (GE Healthcare, Japan). An indirect competitive assay was
applied for cortisol measurements. 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffered saline (HBS,
150 mM NaCl, 0.05% Tween 20, pH 7.4) was used as the running
buffer.
When the antibody solution is injected onto the chip surface,
the antibodies bind to the cortisol analog immobilized onto the
chip surface, resulting in an increased sensor response. The time
from injection to reach the sensor surface is within a few seconds.
The increase in the sensor response (∆θ0) represents the number
of antibodies bound to the chip surface. When a mixture of anti-
bodies and cortisol is injected onto the chip surface, the antibodies
that have already bound to the cortisol do not bind to the cortisol
analog on the chip surface. Namely, the cortisol in the solution
inhibits the antibodies from binding to the chip surface. There-
fore, the concentration of antibodies bound to the chip surface
decreases from that when only the antibodies are injected (∆θ1).
It is considered that ∆θ1 decreases as the percentage of cortisol
in the mixture increases. Here, the relative change in the concen-
tration of antibodies bound to the chip surface, i.e., the bound
percentage, is calculated by
(∆θ1/∆θ0)× 100. (1)
The smaller the bound percentage, the larger the concentration of
antibodies bound to cortisol. Antibodies and cortisol, each with a
concentration of twice the final concentration, were prepared for
the measurement.
A mixture of the antibody solution and HBS buffer was injected
onto the chip surface for 5 min, followed by the injection of a
regeneration solution for 3 min at a flow rate of 15µl/min to
regenerate the chip surface. Subsequently, the antibody and corti-
sol solutions were mixed with a ratio of 1:1 and injected onto the
chip surface for 5 min at a flow rate of 15µl/min. Next, to regen-
erate the sensor surface, 50 mM NaOH was allowed to flow over
the sensor surface for 3 min at a flow rate of 15µl/min.
CALCULATION OF ASSOCIATION CONSTANT
Antibody solutions with different concentrations (0.1–2.0 ppm)
were injected onto the three sensor chips with the cortisol analog
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FIGURE 1 | Fabrication procedure of the sensor chip modified with cortisol analog.
immobilized on the surface for 5 min at 30µL/min. After the injec-
tion, the sensor chip was incubated for 5 min to allow spontaneous
dissociation. The obtained sensorgram was used to calculate the
reaction rate constants. BIAevaluation version 4.1 software (GE
Healthcare Bio-Science) was used for analysis as well as the “biva-
lent with mass transfer”fitting model,which assumes that antibod-
ies undergo bivalent binding and that the association of antibodies
occurs under mass transport limitation. Five sensorgrams with
six concentrations of the antibody solution were simultaneously
analyzed by the fitting program to calculate the association rate
constant K a and the dissociation rate constant K d. Using these
constants, the association constant KA (=K a/K d) was calculated.
CALIBRATION CURVE FOR CORTISOL DETECTION
To construct a calibration curve, the sensor response was measured
three times for each cortisol solution with concentrations of 0.01–
100 ppb (1 ppb= 1µg/l= 2.8 nM) following the above procedure.
A bound percentage equal to a value three times the standard devi-
ation was adopted as the detection limit. BIAevaluation version 4.1
software (GE Healthcare Bio-Science) was used for calculating the
calibration curves.
COLLECTION AND PREPARATION OF HUMAN SALIVA SAMPLES
To collect human saliva, four healthy young Japanese adults
(25± 1.2 years) were enrolled in this study. The study protocol
was approved by the Ethical Committee of Kyushu University.
The subjects were not allowed to take any food or drinks, except
for water, for 1 h prior to the collection. To clean the oral cavity,
each subject rinsed their mouth. To collect whole saliva, the sub-
jects inserted a salimetrics oral swab into the oral cavity under the
tongue for about 3 min. Saliva was collected at 10:00 a.m., 2:00,
and 6:00 p.m. The saliva was separated from the oral swab by cen-
trifugalization at 3,000 rpm for 15 min. Then, the saliva samples
were stored at−20°C until analysis.
RESULTS AND DISCUSSION
EVALUATION OF ASSOCIATION CONSTANTS OF THE CORTISOL ANALOG
TO THE ANTIBODY
In order to confirm that the hydrocortisone 3-(O-carboxymethyl)
oxime (hydrocortisone 3-CMO) can be applied to this indirect
competitive assay as a cortisol analog, the strength of association
constants (KA) of the modified sensor chip was analyzed. From
the calculation result, KA was 3.07× 107 M−1 and lower than KA
between cortisol and the cortisol antibody (KA= 1.7× 109 M−1).
It indicated that the cortisol analog-modified sensor chip can be
applied to the indirect competitive assay.
CALIBRATION CURVE
A calibration curve for the cortisol measurement was obtained
using a standard cortisol solution consisting of cortisol with var-
ious concentrations, HBS, and 2.5% ethanol (n= 3). Figure 2
shows an SPR sensorgram obtained by this measurement. When
a mixture of 600 ppb antibody and HBS (final concentration,
300 ppb) was injected onto the chip, the change in the sen-
sor response (∆θ1) was 207.4± 4.7 RU (n= 18). Here, 1000
RU corresponds to approximately 1 ng/mm2, and the amount
of immobilized antibody was 207.4 pg/mm2. Dissociation of the
bound antibody from the sensing surface is required for the
next immunocycle. These results indicate that the regeneration
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Tahara et al. SPR immunosensor for salivary cortisol
FIGURE 2 | Surface plasmon resonance sensorgram obtained from indirect competitive assay.
conditions are suitable, because the sensor responses (∆θ1) were
nearly unchanged.
Before injection onto the sensor surface, each mixture of the
antibody and cortisol solutions was incubated for 2 h. A mix-
ture solution containing 600 ppb antibody and the each stan-
dard cortisol solution was applied for 5 min after incubation for
2 h or without incubation before injection. Figure 3 shows the
obtained calibration curves. Even without incubation, a calibra-
tion curve similar to that for the case of 2 h incubation was
obtained. The detection limits of the calibration curves in the
case of 2 h incubation and no incubation were 72.8 and 38.0 ppt,
respectively. Alderling et al. reported that the cortisol level in
human saliva ranges from approximately 2–20 nM (0.7–7.1 ppb)
with circadian variation. Thus, this cortisol immuno-assay method
does not need sample incubation, antibody, and cortisol solu-
tion, before sample injection to monitor human cortisol levels.
Here, ∆θ1 for cortisol quantification was determined approxi-
mately 8 min after sample injection and rapid compared with
other reports. Moreover, it can be used to analyze the cortisol
concentrations in blood plasma and urine, which are approxi-
mately 10 times higher than that in saliva, upon controlling the
sensitivity.
COMPARISON OF SPR AND ELISA ASSAY
To evaluate the accuracy of the cortisol biosensor for detecting
cortisol in human saliva, we carried out a comparison with a
conventional cortisol ELISA kit. The calibration curve for the
cortisol measurement was applied using standard cortisol solu-
tion included in a commercialized ELISA kit (n= 2). Figure 4
shows the calculated cortisol values using the sensor and ELISA
applied to cortisol standard solution (0.12–3 ppb). The values of
FIGURE 3 | Calibration curve of the cortisol biosensor with or without
incubation before injection of cortisol standard cortisol and cortisol
antibody. ; without incubation, ; 2 h incubation.
determination (R2) of the sensor and ELISA were 0.98 and 0.99,
respectively.
In the ELISA assay, after the human saliva samples were
thawed at room temperature, they were centrifuged at 3,000 rpm
for 15 min and the supernatant sample was used in the ELISA
assay. The measurement was performed following the manufac-
turer’s manual. The cortisol concentration ranged between 1.3 and
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FIGURE 4 | Calculated cortisol values using the sensor and ELISA
applied to cortisol standard solution.
4.1 ppb (3.7 and 11.2 nM). These results were shown to be in rea-
sonable agreement with those previously reported (Kirschbaum
and Hellhammer, 2007; Hellhammer et al., 2009). In the SPR
assay, after the human saliva samples were thawed at room tem-
perature, they were centrifuged at 13,000 rpm using a Microcon
centrifugal filter unit membrane (molecular weight cutoff 30 kDa,
Millipore Corporation, USA) and mixed with HBS with a volume
ratio of 1:3 to remove proteins. The SPR assay was carried out
following the above procedure. Here, the cross reactivity of the
anti-cortisol antibody to steroid hormones in saliva such as prog-
esterone, testosterone, estradiol, and estriol was lower than 0.1%
according to the data sheet of the manufacturers.
Figure 5 shows the results of the comparative experiment using
human saliva samples. Linear regression analysis was used to deter-
mine the relationship between the measurement values obtained
by the biosensor and the ELISA. The correlation coefficient was
0.96 and the regression equation relative the values of cortisol
obtained using the SPR (CortisolSPR) and ELISA (CortisolELISA)
was CortisolELISA= 0.96×CortisolSPR+ 0.339. The values of
slope ±95% confidence interval (CI) and intercept ±95% were
0.96± 0.239 and 0.339± 0.572, respectively. Thus, it is indicated
that the cortisol immuno-assay has good correlation and is capable
of performing with similar accuracy to the conventional ELISA.
It is necessary to develop the technology for improving sample
preparation method in a short time.
CONCLUSION
A cortisol immuno-assay employing a newly designed indirect
competitive method and a commercially available SPR instrument
with high-sensitivity, rapid, simple, and label-free measurements
was invented for salivary cortisol measurements to replace time-
consuming laboratory analysis and facilitate the POCT of salivary
cortisol. The Au surface of a sensor chip was modified with PEG6-
COOH aromatic dialkanethiol using hydrocortisone 3-CMO as a
FIGURE 5 | Comparison of the measurement values obtained with
cortisol biosensor and ELISA using human saliva samples.
cortisol analog. A detection limit of 38 ppt was achieved by the
sensor and the response time was 5 min from the sample injec-
tion. Moreover, because there was no effect of the incubation time
of standard cortisol and cortisol antibody, cortisol measurement
was possible without incubation. We experimentally compared
our immuno-assay method using the commercially available SPR
instrument with a commercialized salivary cortisol ELISA kit using
human saliva samples. The results obtained by the cortisol biosen-
sor had a good correlation with those obtained by ELISA assay
(R= 0.96). Therefore, the measurement results suggest that the
biosensor can be used to monitor salivary cortisol levels of human
saliva samples. Moreover, it can be used to analyze the cortisol
concentrations in blood plasma and urine.
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